Improving Colorectal Cancer Screening in Primary Care
This study is looking at better ways to help primary care clinics encourage colorectal cancer (CRC) screening. Researchers are comparing two different approaches in 20 clinics across the US. One approach, called NPT-PLA, uses a special method to help clinics learn and act on new ways to improve screening. The other approach uses "usual quality improvement" methods, which are common ways clinics try to get better at what they do. The goal is to see which method helps more patients complete their CRC screening. You might be able to join if you are between 45 and 75 years old and your clinic is participating in the study, especially if your clinic serves communities where at least 25% of people prefer Spanish.
- Study design
- This is an interventional study involving 20 primary care clinics, with 2200 planned participants. Clinics will be randomly assigned to one of two groups: NPT-PLA or usual quality improvement.
- What's involved
- If your clinic participates, you would be invited to complete a screening tool and then monitored for 6 months to see if you completed recommended CRC screening.
- Compensation
- Not stated in the trial record.
- Follow-up
- Patients will be followed for 6 months after being invited to complete the screening tool.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Joseph W LeMaster, MD MPH · PRINCIPAL_INVESTIGATOR · University of Kansas
- Christina Hester, PhD · PRINCIPAL_INVESTIGATOR · DARTNet Institute
- Keith A Greiner, MD MPH · PRINCIPAL_INVESTIGATOR · University of Kansas
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Exclusion
What this trial measures
- Aim 1: Completion of CRC screening orderscontinuously monitored for 6 months after the patient is invited to complete the I2 tool during each clinic's participation month (0-12)
Extracted from patient participant electronic medical records by DARTNet staff, this will be an indicator variable (0= not completed, 1= completed) indicating if the event occurred within 6 months of the date that the patient was first presented the I2 tool
- Aim 1: Completion of recommended CRC screeningContinuously monitored for 6 months after the patient is invited to complete the I2 tool during each clinic's participation month (0-12)
Extracted from patient participant electronic medical records by DARTNet staff, this will be an indicator variable (0= not completed, 1= completed) indicating if the event occurred within 6 months of the date that the patient was first presented the I2 tool
- Aim 2: Summative focus group discussion qualitative dataMonth 7 after inception in each clinic
We have chosen focus group discussions to collect qualitative data in which I-team members will synergistically identify and clarify their views about implementation intervention, as would not take place in individual interviews. The purpose of the focus group discussions is to (1) review the TIDieR survey responses to clear up any questions about treatment fidelity (2), review the workflow maps they made in the initial session and discuss how workflow has changed; and (3) explore levers and barriers to work flow changes to implement I2. These focus group discussions will focus on levers and barriers to implementing I2 using the approach that each clinic has used (NPT-PLA or usual QI) using the 2022 NPT framework that accounts for context. We will audiorecord and transcribe and deidentify focus group interview data for qualitative thematic analysis.